Terms: = Uterine cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
150 results:
1. The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study.
Akakpo PK; Imbeah EG; Ulzen-Appiah K; Darkwa-Abrahams A; Adjei E; Amo-Antwi K; Amo EO; Der EM; Wiredu EK
BMC Infect Dis; 2024 Mar; 24(1):356. PubMed ID: 38539128
[TBL] [Abstract] [Full Text] [Related]
2. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
[TBL] [Abstract] [Full Text] [Related]
3. Multiparametric MRI-based radiomics nomogram for identifying cervix-corpus junction cervical adenocarcinoma from endometrioid adenocarcinoma.
Fang Y; Wang K; Xiao M; Cheng J; Lin Z; Qiang J; Li Y
Abdom Radiol (NY); 2024 May; 49(5):1557-1568. PubMed ID: 38441631
[TBL] [Abstract] [Full Text] [Related]
4. Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.
Chen X; Guo Q; Chen X; Zheng W; Kang Y; Cao D
BMC Med Imaging; 2024 Feb; 24(1):48. PubMed ID: 38373912
[TBL] [Abstract] [Full Text] [Related]
5. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
6. False-Positive Atypical Endocervical Cells in Conventional Pap Smears: Cyto-Histological Correlation and Analysis.
Pulkkinen J; Huhtala H; Kholová I
Acta Cytol; 2023; 67(6):604-617. PubMed ID: 37562375
[TBL] [Abstract] [Full Text] [Related]
7. Endometrioid adenocarcinoma: combined multiparametric MRI and tumour marker HE4 to evaluate tumour grade and lymphovascular space invasion.
Yue XN; He XY; Wu JJ; Fan W; Zhang HJ; Wang CW
Clin Radiol; 2023 Aug; 78(8):e574-e581. PubMed ID: 37183140
[TBL] [Abstract] [Full Text] [Related]
8. 3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma.
Long L; Liu M; Deng X; Cao M; Zhang J; Lan X; Zhang J
Magn Reson Imaging; 2023 Oct; 102():62-68. PubMed ID: 37146780
[TBL] [Abstract] [Full Text] [Related]
9. Multiplex recombinase polymerase amplification for high-risk and low-risk type HPV detection, as potential local use in single tube.
Wongsamart R; Bhattarakasol P; Chaiwongkot A; Wongsawaeng D; Okada PA; Palaga T; Leelahavanichkul A; Khovidhunkit W; Dean D; Somboonna N
Sci Rep; 2023 Jan; 13(1):829. PubMed ID: 36646782
[TBL] [Abstract] [Full Text] [Related]
10. Using Silva pattern system to predict prognosis and plan treatment of invasive endocervical adenocarcinoma: a single-center retrospective analysis.
Li X; Pang S; Shen Y; Qu P
BMC Womens Health; 2022 Dec; 22(1):488. PubMed ID: 36460984
[TBL] [Abstract] [Full Text] [Related]
11. Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
Li Y; Jia M; Cao L; Yu J; Gao H; Sun PL
BMC Cancer; 2022 Nov; 22(1):1172. PubMed ID: 36376880
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic utility of ThinPrep Imaging System® for detecting atypical glandular cells in cervical smear samples.
Akca Y; Erkilic S
Diagn Cytopathol; 2023 Feb; 51(2):135-139. PubMed ID: 36308412
[TBL] [Abstract] [Full Text] [Related]
13. Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
Lee Y; Bae H; Kim HS
Anticancer Res; 2022 Sep; 42(9):4627-4639. PubMed ID: 36039458
[TBL] [Abstract] [Full Text] [Related]
14. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
He Z; Xie C; Qi X; Hu Z; He Y
BMC Womens Health; 2022 Jul; 22(1):314. PubMed ID: 35879712
[TBL] [Abstract] [Full Text] [Related]
15. cyld expression in endometrial carcinoma and correlation with clinicohistopathological parameters.
Papadatou V; Tologkos S; Tsolou A; Deftereou TE; Liberis A; Trypsianis G; Alexiadis T; Georgiadi K; Alexiadi CA; Nikolaidou C; Lambropoulou M
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):596-600. PubMed ID: 35779906
[TBL] [Abstract] [Full Text] [Related]
16. Clinical characteristic and prognostic factors in high-grade endometrial neuroendocrine carcinoma.
Zhang Z; Wang J; Wu X; Liu Y; Xi X
J Obstet Gynaecol Res; 2022 Aug; 48(8):2180-2188. PubMed ID: 35778826
[TBL] [Abstract] [Full Text] [Related]
17. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract] [Full Text] [Related]
18. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract] [Full Text] [Related]
19. Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
Pulkkinen J; Huhtala H; Krogerus LA; Hollmén S; Laurila M; Kholová I
Acta Cytol; 2022; 66(3):206-215. PubMed ID: 35226896
[TBL] [Abstract] [Full Text] [Related]
20. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
Rivera-Colón G; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
[TBL] [Abstract] [Full Text] [Related]
[Next]